Johnson's Baby is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Johnson's Baby was owned by Johnson & Johnson from 1893 to 2023.[2]
Johnson's Baby powder was introduced in 1893 after doctors reported that the talc packaged with medicated plasters soothed irritated skin, and the brand became the archetypal baby toiletries range. Litigation over talc and ovarian cancer led the company to reformulate with cornstarch. The brand moved to Kenvue in 2023.
What Kenvue's annual report says about Johnson's Baby
Sentences about Johnson's Baby from Kenvue's latest annual filing[1], copied word for word.
See " Risks Related to Our Business and Industry Our brands are critical to our success, and damage to our reputation or our brands could adversely affect us." Legal proceedings related to talc or talc-containing products, such as Johnson's Baby Powder, sold outside the United States and Canada and other risks and uncertainties related to talc or talc-containing products could adversely affect us.
A significant number of personal injury claims alleging that talc causes cancer have been made against Old JJCI and J&J arising out of the use of body powders containing talc, primarily Johnson's Baby Powder.
Furthermore, we have been, and may continue to be, subject to claims arising out of the sale of talc-based products that do not constitute Talc-Related Liabilities, such as claims relating to the sale of talc-based Johnson's Baby Powder outside the United States or Canada.
How often Kenvue names Johnson's Baby in its annual report
A plain count of the times the name appears in the text of each annual report, not counting the start of a sentence. A brand that an owner writes about more is usually one it treats as central. The brand is named less often than it was three years earlier.
Kenvue is a publicly listed company headquartered in Summit, New Jersey, United States, founded in 2023. Brandtree records 13 brands under its control, and it is listed as NYSE: KVUE.
Kenvue is the consumer health business separated from Johnson & Johnson, listed in May 2023 and fully split off that August. It holds the self-care, skin health and essential health brands that Johnson & Johnson had built up over a century. Kimberly-Clark agreed to acquire Kenvue in November 2025.
Brandtree records a controlling owner for 2,549 brands that began in the United States.
478 of them (19%) are now controlled by a company headquartered in another country; Johnson's Baby is not one of them.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
Brandtree needs to remember this choice and does not set any other cookie unless you accept.
If you choose “Accept all”, we also use Google Analytics cookies to count visits and see which pages help, so we can improve the site.
If you choose “Accept required”, no analytics cookie is set. Google Analytics still receives a cookieless ping with the page address and your IP address. No advertising is used either way. Privacy policy